Advertisement

Usefulness of Right-to-Left Shunting and Poor Exercise Gas Exchange for Predicting Prognosis in Patients With Pulmonary Arterial Hypertension

      We hypothesized that the longitudinal changes in peak oxygen uptake, ventilatory efficiency, and exercise-induced right-to-left shunting in patients with pulmonary arterial hypertension (PAH) would predict outcomes better than baseline measurements alone. Patients with PAH die prematurely. Identifying prognostic markers is critical for treating patients with PAH; however, longitudinal prognostic information of PAH is limited. We enrolled 103 patients with PAH into a long-term, prospective outcome study using serial cardiopulmonary exercise testing to measure the peak oxygen uptake, ventilatory efficiency (ratio of ventilation to carbon dioxide output at the anaerobic threshold), right-to-left shunting, and other factors in patients treated with optimal therapy. The patients were followed up for a mean of 4.7 years. During the study period, 20 patients died, and 3 underwent lung transplantation. The baseline peak oxygen uptake and ventilatory efficiency was 0.79 L/min and 49 (normal <34), respectively, reflecting severe disease. Poorer ventilatory efficiency and greater New York Heart Association classification were associated with poor outcome at baseline and at follow-up. On multivariate analysis, the persistence or development of an exercise-induced right-to-left shunt strongly predicted death or transplantation (p <0.0001), independent of the hemodynamics and all other exercise measures, including peak oxygen uptake and ventilatory efficiency. The absence of a shunt at baseline was associated with a 20% rate of nonsurvival, which decreased to 7% at follow-up. A poorer ventilatory efficiency appeared to be associated with a poor outcome in patients without a shunt. In conclusion, a persistent exercise-induced right-to-left shunt and poor ventilatory efficiency were highly predictive of poor outcomes in patients with pulmonary arterial hypertension.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Markowitz D.H.
        • Systrom D.M.
        Diagnosis of pulmonary vascular limit to exercise by cardiopulmonary exercise testing.
        J Heart Lung Transplant. 2004; 23: 88-95
        • Sun X.G.
        • Hansen J.E.
        • Oudiz R.J.
        • Wasserman K.
        Exercise pathophysiology in patients with primary pulmonary hypertension.
        Circulation. 2001; 104: 429-435
        • Opitz C.F.
        • Wensel R.
        • Winkler J.
        • Halank M.
        • Bruch L.
        • Kleber F.X.
        • Höffken G.
        • Anker S.D.
        • Negassa A.
        • Felix S.B.
        • Hetzer R.
        • Ewert R.
        Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.
        Eur Heart J. 2005; 26: 1895-1902
        • Oudiz R.J.
        • Roveran G.
        • Sun X.-G.
        • Hansen J.E.
        • Wasserman K.
        Cardiopulmonary responses to sildenafil in pulmonary arterial hypertension.
        Eur J Heart Fail. 2007; 9: 917-921
        • Wensel R.
        • Opitz C.F.
        • Anker S.D.
        • Winkler J.
        • Höffken G.
        • Kleber F.X.
        • Sharma R.
        • Hummel M.
        • Hetzer R.
        • Ewert R.
        Assessment of survival in patients with primary pulmonary hypertension: importance of cardiopulmonary exercise testing.
        Circulation. 2002; 106: 319-324
        • Rich S.
        • Lam W.
        Atrial septostomy as palliative therapy for refractory primary pulmonary hypertension.
        Am J Cardiol. 1983; 51: 1560-1561
        • Barst R.J.
        Role of atrial septostomy in the treatment of pulmonary vascular disease.
        Thorax. 2000; 55: 95-96
        • Sun X.G.
        • Hansen J.E.
        • Oudiz R.J.
        • Wasserman K.
        Gas exchange detection of exercise-induced right-to-left shunt in patients with primary pulmonary hypertension.
        Circulation. 2002; 105: 54-60
        • Simonneau G.
        • Robbins I.M.
        • Beghetti M.
        • Channick R.N.
        • Delcroix M.
        • Denton C.P.
        • Elliott C.G.
        • Gaine S.P.
        • Gladwin M.T.
        • Jing Z.C.
        • Krowka M.J.
        • Langleben D.
        • Nakanishi N.
        • Souza R.
        Updated clinical classification of pulmonary hypertension.
        J Am Coll Cardiol. 2009; 54: S43-S54
        • McLaughlin V.V.
        • Archer S.L.
        • Badesch D.B.
        • Barst R.J.
        • Farber H.W.
        • Lindner J.R.
        • Mathier M.A.
        • McGoon M.D.
        • Park M.H.
        • Rosenson R.S.
        • Rubin L.J.
        • Tapson V.F.
        • Varga J.
        ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association.
        J Am Coll Cardiol. 2009; 53: 1573-1619
        • Wasserman K.
        • Hansen J.E.
        • Sue D.Y.
        • Stringer W.W.
        • Whipp B.J.
        Principles of Exercise Testing and Interpretation.
        in: 4th ed. Lippincott, Williams & Wilkins, Philadelphia2005: 568
        • Beaver W.L.
        • Wasserman K.
        • Whipp B.J.
        A new method for detecting the anaerobic threshold by gas exchange.
        J Appl Physiol. 1986; 60: 2020-2027
        • Hansen J.E.
        • Sun X.G.
        • Yasunobu Y.
        • Garafano R.P.
        • Gates G.
        • Barst R.J.
        • Wasserman K.
        Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension.
        Chest. 2004; 126: 816-824
        • Rozkovec A.
        • Montanes P.
        • Oakley C.M.
        Factors that influence the outcome of primary pulmonary hypertension.
        Br Heart J. 1986; 55: 449-458
        • Paciocco G.
        • Martinez F.J.
        • Bossone E.
        • Pielsticker E.
        • Gillespie B.
        • Rubenfire M.
        Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension.
        Eur Respir J. 2001; 17: 647-652
        • Hansen J.E.
        • Casaburi R.
        Validity of ear oximetry in clinical exercise testing.
        Chest. 1987; 91: 333-337
        • Groepenhoff H.
        • Vonk-Noordegraaf A.
        • Boonstra A.
        • Spreeuwenberg M.D.
        • Postmus P.E.
        • Bogaard H.J.
        Exercise testing to estimate survival in pulmonary hypertension.
        Med Sci Sports Exerc. 2008; 40: 1725-1732
        • Guyatt G.H.
        • Sullivan M.J.
        • Thompson P.J.
        The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.
        Can Med Assoc J. 1985; 132: 919-923
        • Oudiz R.J.
        • Barst R.J.
        • Hansen J.E.
        • Sun X.G.
        • Garofano R.
        • Wu X.
        • Wasserman K.
        Cardiopulmonary exercise testing and six-minute walk correlations in pulmonary arterial hypertension.
        Am J Cardiol. 2006; 97: 123-126